Home
Conditions
Tauopathies

Clinical trial condition

Tauopathies

Explore clinical trials studying Tauopathies. Study availability and eligibility vary by location and protocol.

3,028 public trials 538 recruiting studies

Refine in advanced search Browse all conditions

Tauopathies trial results

Completed

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

NCT02632786

Conditions: AL Amyloidosis, Alzheimer Disease, Amyloidosis, +22 more
Locations: City of Hope Duarte, California, United States

Stanford Cancer Institute (SCI) Stanford, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Mayo Clinic Jacksonville, Florida, United States

View all 40 locations

View Trial Details

Completed

Davunetide (AL-108) in Predicted Tauopathies - Pilot Study

NCT01056965

Conditions: Aphasia, Aphasia, Primary Progressive, Basal Ganglia Diseases, +35 more
Locations: University of California, San Francisco (UCSF) San Francisco, California, United States

View Trial Details

Completed

A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly

NCT02172612

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Sander's BrownCenter on Aging Lexington, Kentucky, United States

View Trial Details

Completed

Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease

NCT02409030

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: AZ Sint Jan Bruges, Belgium

UCL St Luc Brussels, Belgium

Centre Hospitalier d'ARRAS Arras, France

Hôpital neurologique Pierre Wertheimer Bron, France

View all 16 locations

View Trial Details

Completed

Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

NCT03058965

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +19 more
Locations: Molecular NeuroImaging, LLC New Haven, Connecticut, United States

View Trial Details

Completed

Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

NCT00456417

Conditions: Alzheimer Disease, Alzheimers Disease, Brain Diseases, +10 more
Locations: Institute for Neurodegenerative Disorders New Haven, Connecticut, United States

View Trial Details

Completed

Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

NCT00556660

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Institute for Neurodegenerative Disorders New Haven, Connecticut, United States

Molecular NeuroImaging, LLC New Haven, Connecticut, United States

View Trial Details

Completed

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

NCT02553928

Conditions: Alzheimer Dementia (AD), Alzheimer Disease, Brain Diseases, +7 more
Locations: CN001 Beijing, China

CN006 Fujian, China

CN004 Shandong, China

CN002 Tianjin, China

View Trial Details

Completed

Mild Cognitive Impairment and Obstructive Sleep Apnea

NCT01482351

Conditions: Alzheimer Disease, Apnea, Brain Diseases, +21 more
Locations: Abington Memorial Hospital Abington, Pennsylvania, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

George Mason University Fairfax, Virginia, United States

View Trial Details

Completed

Evaluating Simvastatin's Potential Role in Therapy

NCT00486044

Conditions: Alzheimer Disease, Amyloidosis, Brain Diseases, +13 more
Locations: University of Wisconsin Madison, Wisconsin, United States

View Trial Details

Tauopathies

Tauopathies trial results

Related conditions